Atypical Skin Reaction to Rivastigmine Patch
Author Information
Author(s): T. Grieco, M. Rossi, V. Faina, I. De Marco, P. Pigatto, S. Calvieri
Primary Institution: Department of Dermatology, Universitá di Roma “La Sapienza”
Hypothesis
Is there a specific hypersensitivity to the rivastigmine transdermal patch in patients with Alzheimer's dementia?
Conclusion
The patient exhibited a specific hypersensitivity to the rivastigmine patch, confirmed by positive patch tests.
Supporting Evidence
- The patient developed skin lesions after 15 days of using the rivastigmine patch.
- Patch tests confirmed hypersensitivity to the rivastigmine patch.
- Skin lesions fully remitted one month after stopping the patch.
Takeaway
One patient had a bad skin reaction to a patch used for Alzheimer's treatment, showing that some people can be allergic to it.
Methodology
The patient underwent allergological testing with patch tests to confirm hypersensitivity.
Limitations
The study is based on a single case report, limiting generalizability.
Participant Demographics
75-year-old male patient with Alzheimer's dementia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website